BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 17927741)

  • 1. Oral administration of Bifidobacterium longum prevents gut-derived Pseudomonas aeruginosa sepsis in mice.
    Matsumoto T; Ishikawa H; Tateda K; Yaeshima T; Ishibashi N; Yamaguchi K
    J Appl Microbiol; 2008 Mar; 104(3):672-80. PubMed ID: 17927741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains.
    Yoshimura K; Matsui T; Itoh K
    Antonie Van Leeuwenhoek; 2010 Feb; 97(2):107-17. PubMed ID: 19911297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifidobacterium as an oral delivery carrier of oxyntomodulin for obesity therapy: inhibitory effects on food intake and body weight in overweight mice.
    Long RT; Zeng WS; Chen LY; Guo J; Lin YZ; Huang QS; Luo SQ
    Int J Obes (Lond); 2010 Apr; 34(4):712-9. PubMed ID: 20065960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Bifidobacterium longum ingestion on experimental salmonellosis in mice.
    Silva AM; Barbosa FH; Duarte R; Vieira LQ; Arantes RM; Nicoli JR
    J Appl Microbiol; 2004; 97(1):29-37. PubMed ID: 15186439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical synergistic effects of tumour necrosis factor and interleukin 1 in murine gut-derived sepsis with Pseudomonas aeruginosa.
    Matsumoto T; Tateda K; Miyazaki S; Furuya N; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
    Cytokine; 1999 May; 11(5):366-72. PubMed ID: 10328876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of tumour necrosis factor in cyclophosphamide-treated mice subjected to gut-derived Pseudomonas aeruginosa sepsis.
    Matsumoto T; Tateda K; Miyazaki S; Furuya N; Ohno A; Ishii Y; Hirakata Y; Yamaguchi K
    Cytokine; 1997 Oct; 9(10):763-9. PubMed ID: 9344509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety evaluation of Bifidobacterium pseudocatenulatum G4 as assessed in BALB/c mice.
    Kabeir BM; Yazid AM; Stephenie W; Hakim MN; Anas OM; Shuhaimi M
    Lett Appl Microbiol; 2008 Jan; 46(1):32-7. PubMed ID: 17944838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-treatment with probiotics prolongs survival after experimental infection by multidrug-resistant Pseudomonas aeruginosa in rodents: an effect on sepsis-induced immunosuppression.
    Machairas N; Pistiki A; Droggiti DI; Georgitsi M; Pelekanos N; Damoraki G; Kouraklis G; Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2015 Apr; 45(4):376-84. PubMed ID: 25601531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1-deficient mice exhibit high sensitivity to gut-derived sepsis caused by Pseudomonas aeruginosa.
    Horino T; Matsumoto T; Uramatsu M; Tanabe M; Tateda K; Miyazaki S; Nakane A; Iwakura Y; Yamaguchi K
    Cytokine; 2005 Jun; 30(6):339-46. PubMed ID: 15935954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety assessment of potential lactic acid bacteria Bifidobacterium longum SPM1205 isolated from healthy Koreans.
    Choi SS; Kang BY; Chung MJ; Kim SD; Park SH; Kim JS; Kang CY; Ha NJ
    J Microbiol; 2005 Dec; 43(6):493-8. PubMed ID: 16410764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic acid water feeding protects mice against lethal gut-derived sepsis due to Pseudomonas aeruginosa.
    Wu L; Kohler JE; Zaborina O; Akash G; Musch MW; Chang EB; Alverdy JC
    Curr Issues Intest Microbiol; 2006 Mar; 7(1):19-28. PubMed ID: 16570696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: the potential use of probiotics in wound treatment.
    Valdéz JC; Peral MC; Rachid M; Santana M; Perdigón G
    Clin Microbiol Infect; 2005 Jun; 11(6):472-9. PubMed ID: 15882197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability.
    Abe F; Muto M; Yaeshima T; Iwatsuki K; Aihara H; Ohashi Y; Fujisawa T
    Anaerobe; 2010 Apr; 16(2):131-6. PubMed ID: 19638311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial.
    Jain PK; McNaught CE; Anderson AD; MacFie J; Mitchell CJ
    Clin Nutr; 2004 Aug; 23(4):467-75. PubMed ID: 15297081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral administration of live Bifidobacterium substrains isolated from healthy centenarians enhanced immune function in BALB/c mice.
    Yang HY; Liu SL; Ibrahim SA; Zhao L; Jiang JL; Sun WF; Ren FZ
    Nutr Res; 2009 Apr; 29(4):281-9. PubMed ID: 19410981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations on the efficacy of monovalent Pseudomonas aeruginosa vaccine for oral administration in Pseudomonas aeruginosa experimental infection.
    Meitert E; Sima F; Savulian C; Petrovici M; Chersulick E; Costache G
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):237-51. PubMed ID: 2519634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of production conditions on the stability of a human bifidobacterial species Bifidobacterium longum in yogurt.
    Abe F; Tomita S; Yaeshima T; Iwatsuki K
    Lett Appl Microbiol; 2009 Dec; 49(6):715-20. PubMed ID: 19818009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteria and chocolate: a successful combination for probiotic delivery.
    Possemiers S; Marzorati M; Verstraete W; Van de Wiele T
    Int J Food Microbiol; 2010 Jun; 141(1-2):97-103. PubMed ID: 20452073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sepsis from Pseudomonas aeruginosa pneumonia decreases intestinal proliferation and induces gut epithelial cell cycle arrest.
    Coopersmith CM; Stromberg PE; Davis CG; Dunne WM; Amiot DM; Karl IE; Hotchkiss RS; Buchman TG
    Crit Care Med; 2003 Jun; 31(6):1630-7. PubMed ID: 12794397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.
    Morinaga Y; Yanagihara K; Nakamura S; Yamamoto K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S
    J Antimicrob Chemother; 2008 Dec; 62(6):1326-31. PubMed ID: 18835805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.